Location: Rotterdam, Netherlands
Start Date: 3/04/2020
End Date: 3/05/2020
The inaugural International Cannabinoid-Based Drug Discovery and Development (iCBD3) Congress will explore an array of drug targets, therapies, manufacturing processes, regulatory frameworks, clinical studies and market opportunities for cannabinoid-based pharmaceuticals.
This programme creates a collaborative environment in which you can create enduring relationships across the full range of cannabinoid pharmaceutical discovery and development.
Visit the webpage to view the full range of presentations.